Yahoo Web Search

Search results

  1. Nov 9, 2023 · Today, the U.S. Food and Drug Administration approved Ixchiq, the first chikungunya vaccine. Ixchiq is approved for individuals 18 years of age and older who are at increased risk of exposure...

  2. Key points. One chikungunya vaccine (called IXCHIQ) is available in the United States. Some travelers at higher risk of exposure to chikungunya virus or at increased risk of severe disease should consider this vaccine. Talk to your healthcare provider if traveling to an area with risk for chikungunya.

  3. Nov 10, 2023 · CNN — The US Food and Drug Administration said Thursday that it has approved the first vaccine to prevent disease caused by the chikungunya virus. The single-dose vaccine, Ixchiq, made by...

  4. May 20, 2024 · One chikungunya vaccine (manufactured by Valneva and called IXCHIQ) is available in the United States. The vaccine is licensed for adults aged 18 years and older. The vaccine should be considered for some travelers at higher risk of exposure to chikungunya virus or at increased risk of severe disease.

  5. Nov 9, 2023 · Nov 09, 2023, 17:35 ET. Share this article. SILVER SPRING, Md., Nov. 9, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Ixchiq, the first chikungunya vaccine. Ixchiq...

  6. Nov 9, 2023 · Ixchiq, the world’s first chikungunya vaccine, was approved by the U.S. Food and Drug Administration on November 9, 2023. The WHO describes chikungunya as a disease that causes fever and severe joint pain, often debilitating and varied in duration.

  7. Dec 4, 2023 · Asher Mullard. The FDA has approved Valneva’s chikungunya virus vaccine Ixchiq for adults at risk of exposure to the virus. The company will focus on selling the first-in-class vaccine to...

  1. People also search for